{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:49:36Z","timestamp":1793213376065,"version":"4.5.0"},"reference-count":134,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41574-025-01200-1","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T10:36:35Z","timestamp":1764239795000},"page":"287-301","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["An update on hypophysitis"],"prefix":"10.1038","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3510-0509","authenticated-orcid":false,"given":"Lea","family":"Miquel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benoit","family":"Testud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Albarel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Appay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Graillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8440-0030","authenticated-orcid":false,"given":"Thomas","family":"Cuny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"Dufour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Ebbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8482-6691","authenticated-orcid":false,"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Andr\u00e9","family":"Jarrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-3392","authenticated-orcid":false,"given":"Nicolas","family":"Schleinitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1808-8800","authenticated-orcid":false,"given":"Frederic","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"1200_CR1","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/path.1700830241","volume":"83","author":"RB Goudie","year":"1962","unstructured":"Goudie, R. B. & Pinkerton, P. H. Anterior hypophysitis and Hashimoto\u2019s disease in a young woman. J. Pathol. Bacteriol. 83, 584\u2013585 (1962).","journal-title":"J. Pathol. Bacteriol."},{"key":"1200_CR2","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-22-0689","volume":"187","author":"ES Husebye","year":"2022","unstructured":"Husebye, E. S. et al. Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline. Eur. J. Endocrinol. 187, G1\u2013G21 (2022). These are the latest recommendations for the treatment of immune checkpoint inhibitor-induced hypophysitis.","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41574-021-00484-3","volume":"17","author":"JJ Wright","year":"2021","unstructured":"Wright, J. J., Powers, A. C. & Johnson, D. B. Endocrine toxicities of immune checkpoint inhibitors. Nat. Rev. Endocrinol. 17, 389\u2013399 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1200_CR4","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1200\/JCO.21.01440","volume":"39","author":"BJ Schneider","year":"2021","unstructured":"Schneider, B. J. et al. Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: ASCO guideline update. J. Clin. Oncol. 39, 4073\u20134126 (2021).","journal-title":"J. Clin. Oncol."},{"key":"1200_CR5","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1093\/ejendo\/lvad003","volume":"188","author":"J Honegger","year":"2023","unstructured":"Honegger, J., Giese, S., Nasi-Kordhishti, I. & Donegan, D. M. Pregnancy-related hypophysitis revisited. Eur. J. Endocrinol. 188, R1\u2013R12 (2023). This is the largest study comparing hypophysitis related and unrelated to pregnancy.","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR6","doi-asserted-by":"publisher","first-page":"e1767","DOI":"10.1210\/clinem\/dgae664","volume":"110","author":"L Miquel","year":"2024","unstructured":"Miquel, L. et al. Deciphering the presentation and etiologies of hypophysitis highlights the need for repeated systematical investigation. J. Clin. Endocrinol. Metab. 110, e1767\u2013e1775 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/qjmed\/hcs121","volume":"105","author":"C Langrand","year":"2012","unstructured":"Langrand, C. et al. Hypothalamo-pituitary sarcoidosis: a multicenter study of 24 patients. QJM 105, 981\u2013995 (2012).","journal-title":"QJM"},{"key":"1200_CR8","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1530\/EJE-19-0177","volume":"181","author":"Y Sagna","year":"2019","unstructured":"Sagna, Y. et al. Endocrine manifestations in a cohort of 63 adulthood and childhood onset patients with Langehans cell histiocytosis. Eur. J. Endocrinol. 181, 275\u2013285 (2019). With 40 adults and 23 children, this is the largest retrospective cohort with pituitary involvement in patients with Langerhans cell histiocytosis.","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR9","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1210\/jc.2015-3357","volume":"101","author":"C Courtillot","year":"2016","unstructured":"Courtillot, C. et al. Endocrine manifestations in a monocentric cohort of 64 patients with erdheim-chester disease. J. Clin. Endocrinol. Metab. 101, 305\u2013313 (2016). This article represents the largest endocrine retrospective cohort of patients with Erdheim\u2013Chester disease.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR10","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s12020-021-02714-0","volume":"73","author":"A Amirbaigloo","year":"2021","unstructured":"Amirbaigloo, A., Esfahanian, F., Mouodi, M., Rakhshani, N. & Zeinalizadeh, M. IgG4-related hypophysitis. Endocrine 73, 270\u2013291 (2021).","journal-title":"Endocrine"},{"key":"1200_CR11","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser, E. D. et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society clinical practice guideline. Am. J. Respir. Crit. Care Med. 201, e26\u2013e51 (2020).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"1200_CR12","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1182\/blood-2016-01-690636","volume":"127","author":"J-F Emile","year":"2016","unstructured":"Emile, J.-F. et al. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood 127, 2672\u20132681 (2016).","journal-title":"Blood"},{"key":"1200_CR13","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s41584-025-01240-x","volume":"21","author":"F Peyronel","year":"2025","unstructured":"Peyronel, F. et al. IgG4-related disease and other fibro-inflammatory conditions. Nat. Rev. Rheumatol. 21, 275\u2013290 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1200_CR14","doi-asserted-by":"publisher","first-page":"K1","DOI":"10.1093\/ejendo\/lvad179","volume":"190","author":"S Urai","year":"2024","unstructured":"Urai, S. et al. Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. Eur. J. Endocrinol. 190, K1\u2013K7 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1210\/clinem\/dgab672","volume":"107","author":"F Langlois","year":"2021","unstructured":"Langlois, F., Varlamov, E. V. & Fleseriu, M. Hypophysitis, the growing spectrum of a rare pituitary disease. J. Clin. Endocrinol. Metab. 107, 10\u201328 (2021). This article reviews the different types and causes of hypophysitis, major published cohort series and diagnostic and therapeutic approaches.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR16","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/ERC-18-0320","volume":"26","author":"F Castinetti","year":"2018","unstructured":"Castinetti, F. et al. French Endocrine Society guidance on endocrine side effects of immunotherapy. Endocr. Relat. Cancer 26, G1\u2013G18 (2018).","journal-title":"Endocr. Relat. Cancer"},{"key":"1200_CR17","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1210\/clinem\/dgad670","volume":"109","author":"I Vardarli","year":"2024","unstructured":"Vardarli, I. et al. Risk and incidence of endocrine immune-related adverse effects under checkpoint inhibitor mono- or combination therapy in solid tumors: a meta-analysis of randomized controlled trials. J. Clin. Endocrinol. Metab. 109, 1132\u20131144 (2024).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1210\/er.2004-0011","volume":"26","author":"P Caturegli","year":"2005","unstructured":"Caturegli, P. et al. Autoimmune hypophysitis. Endocr. Rev. 26, 599\u2013614 (2005).","journal-title":"Endocr. Rev."},{"key":"1200_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2265.2009.03765.x","volume":"73","author":"TA Howlett","year":"2010","unstructured":"Howlett, T. A., Levy, M. J. & Robertson, I. J. How reliably can autoimmune hypophysitis be diagnosed without pituitary biopsy. Clin. Endocrinol. 73, 18\u201321 (2010).","journal-title":"Clin. Endocrinol."},{"key":"1200_CR20","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1080\/02688690120057664","volume":"15","author":"N Buxton","year":"2001","unstructured":"Buxton, N. & Robertson, I. Lymphocytic and granulocytic hypophysitis: a single centre experience. Br. J. Neurosurg. 15, 242\u2013246 (2001).","journal-title":"Br. J. Neurosurg."},{"key":"1200_CR21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.20945\/2359-3997000000102","volume":"63","author":"NN Imga","year":"2019","unstructured":"Imga, N. N., Yildirim, A. E., Baser, O. O. & Berker, D. Clinical and hormonal characteristics of patients with different types of hypophysitis: a single-center experience. Arch. Endocrinol. Metab. 63, 47\u201352 (2019).","journal-title":"Arch. Endocrinol. Metab."},{"key":"1200_CR22","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1097\/00006123-199704000-00010","volume":"40","author":"J Honegger","year":"1997","unstructured":"Honegger, J. et al. Lymphocytic and granulomatous hypophysitis: experience with nine cases. Neurosurgery 40, 713\u2013723 (1997).","journal-title":"Neurosurgery"},{"key":"1200_CR23","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3171\/jns.2004.101.2.0262","volume":"101","author":"GKK Leung","year":"2004","unstructured":"Leung, G. K. K., Lopes, M.-B. S., Thorner, M. O., Vance, M. L. & Laws, E. R. Primary hypophysitis: a single-center experience in 16 cases. J. Neurosurg. 101, 262\u2013271 (2004).","journal-title":"J. Neurosurg."},{"key":"1200_CR24","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/BF00318578","volume":"90","author":"D Sautner","year":"1995","unstructured":"Sautner, D., Saeger, W., L\u00fcdecke, D. K., Jansen, V. & Puchner, M. J. Hypophysitis in surgical and autoptical specimens. Acta Neuropathol. 90, 637\u2013644 (1995).","journal-title":"Acta Neuropathol."},{"key":"1200_CR25","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/01.pas.0000149707.12335.8e","volume":"29","author":"A Gutenberg","year":"2005","unstructured":"Gutenberg, A., Buslei, R., Fahlbusch, R., Buchfelder, M. & Br\u00fcck, W. Immunopathology of primary hypophysitis: implications for pathogenesis. Am. J. Surg. Pathol. 29, 329\u2013338 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"1200_CR26","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1385\/EP:13:3:183","volume":"13","author":"T Tashiro","year":"2002","unstructured":"Tashiro, T. et al. Spectrum of different types of hypophysitis: a clinicopathologic study of hypophysitis in 31 cases. Endocr. Pathol. 13, 183\u2013195 (2002).","journal-title":"Endocr. Pathol."},{"key":"1200_CR27","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/ejendo\/lvae101","volume":"191","author":"A Hacioglu","year":"2024","unstructured":"Hacioglu, A. et al. Evaluation and follow-up of patients diagnosed with hypophysitis: a cohort study. Eur. J. Endocrinol. 191, 312\u2013322 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1055\/a-1163-7304","volume":"129","author":"F Amereller","year":"2021","unstructured":"Amereller, F., K\u00fcppers, A.-M., Schilbach, K., Schopohl, J. & St\u00f6rmann, S. Clinical characteristics of primary hypophysitis \u2014 a single-centre series of 60 cases. Exp. Clin. Endocrinol. Diabetes 129, 234\u2013240 (2021).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1200_CR29","first-page":"976","volume":"19","author":"J-S Ju","year":"2023","unstructured":"Ju, J.-S., Cui, T., Zhao, J., Chen, J.-L. & Ju, H.-B. Clinical presentation and magnetic resonance imaging characteristics of lymphocytic hypophysitis: a systematic review with meta-analysis. Arch. Med. Sci. 19, 976\u2013986 (2023).","journal-title":"Arch. Med. Sci."},{"key":"1200_CR30","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1007\/s11102-014-0622-5","volume":"18","author":"BS Imber","year":"2015","unstructured":"Imber, B. S., Lee, H. S., Kunwar, S., Blevins, L. S. & Aghi, M. K. Hypophysitis: a single-center case series. Pituitary 18, 630\u2013641 (2015).","journal-title":"Pituitary"},{"key":"1200_CR31","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1055\/a-0919-4388","volume":"129","author":"OP Korkmaz","year":"2021","unstructured":"Korkmaz, O. P. et al. Primary hypophysitis: experience of a single tertiary center. Exp. Clin. Endocrinol. Diabetes 129, 14\u201321 (2021).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"1200_CR32","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/cen.13354","volume":"87","author":"S Wang","year":"2017","unstructured":"Wang, S. et al. Primary lymphocytic hypophysitis: clinical characteristics and treatment of 50 cases in a single centre in China over 18 years. Clin. Endocrinol. 87, 177\u2013184 (2017).","journal-title":"Clin. Endocrinol."},{"key":"1200_CR33","doi-asserted-by":"publisher","first-page":"e22","DOI":"10.1016\/j.wneu.2019.01.250","volume":"127","author":"Q Zhu","year":"2019","unstructured":"Zhu, Q. et al. Clinical features, magnetic resonance imaging, and treatment experience of 20 patients with lymphocytic hypophysitis in a single center. World Neurosurg. 127, e22\u2013e29 (2019).","journal-title":"World Neurosurg."},{"key":"1200_CR34","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1080\/07435800.2020.1817064","volume":"45","author":"P Atkins","year":"2020","unstructured":"Atkins, P. & Ur, E. Primary and ipilimumab-induced hypophysitis: a single-center case series. Endocr. Res. 45, 246\u2013253 (2020).","journal-title":"Endocr. Res."},{"key":"1200_CR35","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.1210\/clinem\/dgaa771","volume":"106","author":"U T\u00fcre","year":"2021","unstructured":"T\u00fcre, U. et al. Hypothalamitis: a novel autoimmune endocrine disease. a literature review and case report. J. Clin. Endocrinol. Metab. 106, e415\u2013e429 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR36","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1016\/S0140-6736(24)00342-8","volume":"403","author":"M Fleseriu","year":"2024","unstructured":"Fleseriu, M., Christ-Crain, M., Langlois, F., Gadelha, M. & Melmed, S. Hypopituitarism. Lancet 403, 2632\u20132648 (2024).","journal-title":"Lancet"},{"key":"1200_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-025-01526-z","volume":"28","author":"MC Arlien-S\u00f8borg","year":"2025","unstructured":"Arlien-S\u00f8borg, M. C., Karavitaki, N. & Jorgensen, J. O. L. Consensus and controversies about diagnosing GH deficiency: a Delphi survey by the GH Research Society. Pituitary 28, 57 (2025).","journal-title":"Pituitary"},{"key":"1200_CR38","doi-asserted-by":"crossref","unstructured":"Bonneville, J.-F., Bonneville, F., Cattin, F. & Nagi, S. MRI of the Pituitary Gland (Springer, 2016).","DOI":"10.1007\/978-3-319-29043-0"},{"key":"1200_CR39","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s11547-019-01120-x","volume":"125","author":"F Caranci","year":"2020","unstructured":"Caranci, F. et al. Imaging findings in hypophysitis: a review. Radiol. Med. 125, 319\u2013328 (2020).","journal-title":"Radiol. Med."},{"key":"1200_CR40","doi-asserted-by":"publisher","first-page":"1766","DOI":"10.3174\/ajnr.A1714","volume":"30","author":"A Gutenberg","year":"2009","unstructured":"Gutenberg, A., Larsen, J., Lupi, I., Rohde, V. & Caturegli, P. A radiologic score to distinguish autoimmune hypophysitis from nonsecreting pituitary adenoma preoperatively. AJNR Am. J. Neuroradiol. 30, 1766\u20131772 (2009). This article summarizes the radiological features of hypophysitis and proposes a radiological score to differentiate adenoma from hypophysitis. This score is useful in adenoma-like hypophysitis.","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1200_CR41","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1007\/s11604-023-01417-y","volume":"41","author":"R Kurokawa","year":"2023","unstructured":"Kurokawa, R. et al. Neuroimaging of hypophysitis: etiologies and imaging mimics. Jpn. J. Radiol. 41, 911\u2013927 (2023).","journal-title":"Jpn. J. Radiol."},{"key":"1200_CR42","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.3174\/ajnr.A2201","volume":"31","author":"Y Nakata","year":"2010","unstructured":"Nakata, Y. et al. Parasellar T2 dark sign on MR imaging in patients with lymphocytic hypophysitis. AJNR Am. J. Neuroradiol. 31, 1944\u20131950 (2010).","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"1200_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.crad.2015.09.007","volume":"71","author":"G Bathla","year":"2016","unstructured":"Bathla, G., Singh, A. K., Policeni, B., Agarwal, A. & Case, B. Imaging of neurosarcoidosis: common, uncommon, and rare. Clin. Radiol. 71, 96\u2013106 (2016).","journal-title":"Clin. Radiol."},{"key":"1200_CR44","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2214\/ajr.182.2.1820289","volume":"182","author":"JK Smith","year":"2004","unstructured":"Smith, J. K., Matheus, M. G. & Castillo, M. Imaging manifestations of neurosarcoidosis. Am. J. Roentgenol. 182, 289\u2013295 (2004).","journal-title":"Am. J. Roentgenol."},{"key":"1200_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.735655","volume":"12","author":"J Zhu","year":"2021","unstructured":"Zhu, J. et al. Xanthomatous hypophysitis: a case report and comprehensive literature review. Front. Endocrinol. 12, 735655 (2021).","journal-title":"Front. Endocrinol."},{"key":"1200_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/s12022-017-9471-x","volume":"28","author":"K Duan","year":"2017","unstructured":"Duan, K. et al. Xanthomatous hypophysitis is associated with ruptured Rathke\u2019s cleft cyst. Endocr. Pathol. 28, 83\u201390 (2017).","journal-title":"Endocr. Pathol."},{"key":"1200_CR47","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s11102-019-00941-3","volume":"22","author":"S Temizkan","year":"2019","unstructured":"Temizkan, S. & Kelestimur, F. A clinical and pathophysiological approach to traumatic brain injury-induced pituitary dysfunction. Pituitary 22, 220\u2013228 (2019).","journal-title":"Pituitary"},{"key":"1200_CR48","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1365-2265.2011.04056.x","volume":"75","author":"A De Bellis","year":"2011","unstructured":"De Bellis, A. et al. Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism. Clin. Endocrinol. 75, 361\u2013366 (2011).","journal-title":"Clin. Endocrinol."},{"key":"1200_CR49","doi-asserted-by":"publisher","first-page":"E946","DOI":"10.1210\/jc.2014-4209","volume":"100","author":"S Iwama","year":"2015","unstructured":"Iwama, S. et al. Rabphilin-3A as a targeted autoantigen in lymphocytic infundibulo-neurohypophysitis. J. Clin. Endocrinol. Metab. 100, E946\u2013E954 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR50","first-page":"493","volume":"128","author":"Y Ozawa","year":"1993","unstructured":"Ozawa, Y. & Shishiba, Y. Recovery from lymphocytic hypophysitis associated with painless thyroiditis: clinical implications of circulating antipituitary antibodies. Acta Endocrinol. (Copenh.) 128, 493\u2013498 (1993).","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"1200_CR51","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1148\/rg.2021200203","volume":"41","author":"RY Shih","year":"2021","unstructured":"Shih, R. Y., Schroeder, J. W. & Koeller, K. K. Primary tumors of the pituitary gland: radiologic-pathologic correlation. Radiographics 41, 2029\u20132046 (2021).","journal-title":"Radiographics"},{"key":"1200_CR52","doi-asserted-by":"publisher","first-page":"E214","DOI":"10.1148\/rg.210121","volume":"42","author":"J Huang","year":"2022","unstructured":"Huang, J., Sarma, A., Harmsen, H. & Pruthi, S. Systematic approach to evaluating sellar and suprasellar lesions in pediatric patients. Radiographics 42, E214\u2013E215 (2022).","journal-title":"Radiographics"},{"key":"1200_CR53","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1177\/19714009211055195","volume":"35","author":"B Lubomirsky","year":"2022","unstructured":"Lubomirsky, B. et al. Sellar, suprasellar, and parasellar masses: imaging features and neurosurgical approaches. Neuroradiol. J. 35, 269\u2013283 (2022).","journal-title":"Neuroradiol. J."},{"key":"1200_CR54","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s00234-005-0011-x","volume":"48","author":"P Makras","year":"2006","unstructured":"Makras, P. et al. Evolving radiological features of hypothalamo-pituitary lesions in adult patients with Langerhans cell histiocytosis (LCH). Neuroradiology 48, 37\u201344 (2006).","journal-title":"Neuroradiology"},{"key":"1200_CR55","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41574-020-00437-2","volume":"17","author":"F Prodam","year":"2021","unstructured":"Prodam, F., Caputo, M., Mele, C., Marzullo, P. & Aimaretti, G. Insights into non-classic and emerging causes of hypopituitarism. Nat. Rev. Endocrinol. 17, 114\u2013129 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1200_CR56","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1007\/s40618-016-0451-7","volume":"39","author":"C Pelusi","year":"2016","unstructured":"Pelusi, C., Gasparini, D. I., Bianchi, N. & Pasquali, R. Endocrine dysfunction in hereditary hemochromatosis. J. Endocrinol. Invest. 39, 837\u2013847 (2016).","journal-title":"J. Endocrinol. Invest."},{"key":"1200_CR57","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1210\/clinem\/dgab839","volume":"107","author":"D Donegan","year":"2022","unstructured":"Donegan, D. et al. Outcomes of initial management strategies in patients with autoimmune lymphocytic hypophysitis: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 107, 1170\u20131190 (2022). Diagnostic criteria for IgG4-related hypophysitis are proposed in this study.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR58","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.1210\/jc.2015-2152","volume":"100","author":"J Honegger","year":"2015","unstructured":"Honegger, J. et al. Diagnosis of primary hypophysitis in Germany. J. Clin. Endocrinol. Metab. 100, 3841\u20133849 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR59","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11102-013-0550-9","volume":"18","author":"S Khare","year":"2015","unstructured":"Khare, S. et al. Primary (autoimmune) hypophysitis: a single centre experience. Pituitary 18, 16\u201322 (2015).","journal-title":"Pituitary"},{"key":"1200_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1055\/a-1113-7777","volume":"52","author":"SH Oguz","year":"2020","unstructured":"Oguz, S. H. et al. Clinical characteristics, management, and treatment outcomes of primary hypophysitis: a monocentric cohort. Horm. Metab. Res. 52, 220\u2013227 (2020).","journal-title":"Horm. Metab. Res."},{"key":"1200_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00005792-198907000-00006","volume":"68","author":"F Cosman","year":"1989","unstructured":"Cosman, F., Post, K. D., Holub, D. A. & Wardlaw, S. L. Lymphocytic hypophysitis. report of 3 new cases and review of the literature. Medicine 68, 240\u2013256 (1989).","journal-title":"Medicine"},{"key":"1200_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92967-6","volume":"11","author":"M Ramos-Casals","year":"2021","unstructured":"Ramos-Casals, M. et al. Clinical characterization and outcomes of 85 patients with neurosarcoidosis. Sci. Rep. 11, 13735 (2021).","journal-title":"Sci. Rep."},{"key":"1200_CR63","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003277","volume":"95","author":"SE Leonhard","year":"2016","unstructured":"Leonhard, S. E. et al. Neurosarcoidosis in a tertiary referral center: a cross-sectional cohort study. Medicine 95, e3277 (2016).","journal-title":"Medicine"},{"key":"1200_CR64","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001084","volume":"8","author":"MJ Bradshaw","year":"2021","unstructured":"Bradshaw, M. J., Pawate, S., Koth, L. L., Cho, T. A. & Gelfand, J. M. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol. Neuroimmunol. Neuroinflammation 8, e1084 (2021).","journal-title":"Neurol. Neuroimmunol. Neuroinflammation"},{"key":"1200_CR65","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0889-8529(05)70058-X","volume":"28","author":"PU Freda","year":"1999","unstructured":"Freda, P. U. & Post, K. D. Differential diagnosis of sellar masses. Endocrinol. Metab. Clin. North. Am. 28, 81\u2013117 (1999).","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"key":"1200_CR66","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1016\/j.lpm.2012.01.038","volume":"41","author":"H Bihan","year":"2012","unstructured":"Bihan, H. et al. Sarco\u00efdose : l\u2019atteinte des hormones \u00e0 d\u00e9pendance ant\u00e9hypophysaire est insuffisamment diagnostiqu\u00e9e [French]. Presse Med 41, e524\u2013e529 (2012).","journal-title":"Presse Med"},{"key":"1200_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1530\/eje.0.1420365","volume":"142","author":"C Bullmann","year":"2000","unstructured":"Bullmann, C. et al. Five cases with central diabetes insipidus and hypogonadism as first presentation of neurosarcoidosis. Eur. J. Endocrinol. 142, 365\u2013372 (2000).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR68","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/MD.0b013e31815585aa","volume":"86","author":"H Bihan","year":"2007","unstructured":"Bihan, H. et al. Sarcoidosis: clinical, hormonal, and magnetic resonance imaging (MRI) manifestations of hypothalamic-pituitary disease in 9 patients and review of the literature. Medicine 86, 259\u2013268 (2007).","journal-title":"Medicine"},{"key":"1200_CR69","doi-asserted-by":"publisher","first-page":"A92","DOI":"10.1016\/j.revmed.2018.03.331","volume":"39","author":"N Ramos","year":"2018","unstructured":"Ramos, N. et al. Sarco\u00efdose hypothalamo-hypophysaire: \u00e9tude multicentrique de 32 patients [French]. Rev. Med. Interne 39, A92 (2018).","journal-title":"Rev. Med. Interne"},{"key":"1200_CR70","doi-asserted-by":"publisher","first-page":"960","DOI":"10.2169\/internalmedicine.43.960","volume":"43","author":"RP Tabuena","year":"2004","unstructured":"Tabuena, R. P. et al. Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. Intern. Med. 43, 960\u2013966 (2004).","journal-title":"Intern. Med."},{"key":"1200_CR71","doi-asserted-by":"publisher","first-page":"51","DOI":"10.33590\/emjneurol\/10310819","volume":"3","author":"J Martin-Grace","year":"2015","unstructured":"Martin-Grace, J., Murialdo, G. & Tamagno, G. Hypothalamic\u2013pituitary alterations in patients with neurosarcoidosis. EMJ Neurol. 3, 51\u201356 (2015).","journal-title":"EMJ Neurol."},{"key":"1200_CR72","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s11102-015-0678-x","volume":"19","author":"J Anthony","year":"2016","unstructured":"Anthony, J., Esper, G. J. & Ioachimescu, A. Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review. Pituitary 19, 19\u201329 (2016).","journal-title":"Pituitary"},{"key":"1200_CR73","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1056\/NEJM198011063031902","volume":"303","author":"CA Stuart","year":"1980","unstructured":"Stuart, C. A., Neelon, F. A. & Lebovitz, H. E. Disordered control of thirst in hypothalamic-pituitary sarcoidosis. N. Engl. J. Med. 303, 1078\u20131082 (1980).","journal-title":"N. Engl. J. Med."},{"key":"1200_CR74","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre, D. et al. Sarcoidosis. Lancet 383, 1155\u20131167 (2014).","journal-title":"Lancet"},{"key":"1200_CR75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","volume":"58","author":"RP Baughman","year":"2021","unstructured":"Baughman, R. P. et al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur. Respir. J. 58, 2004079 (2021).","journal-title":"Eur. Respir. J."},{"key":"1200_CR76","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1182\/blood.2021014343","volume":"139","author":"G Goyal","year":"2022","unstructured":"Goyal, G. et al. International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults. Blood 139, 2601\u20132621 (2022).","journal-title":"Blood"},{"key":"1200_CR77","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1182\/blood.2019002766","volume":"135","author":"J Haroche","year":"2020","unstructured":"Haroche, J., Cohen-Aubart, F. & Amoura, Z. Erdheim\u2013Chester disease. Blood 135, 1311\u20131318 (2020).","journal-title":"Blood"},{"key":"1200_CR78","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1136\/annrheumdis-2012-202542","volume":"72","author":"G Cavalli","year":"2013","unstructured":"Cavalli, G. et al. The multifaceted clinical presentations and manifestations of Erdheim\u2013Chester disease: comprehensive review of the literature and of 10 new cases. Ann. Rheum. Dis. 72, 1691\u20131695 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"1200_CR79","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1210\/jcem.85.4.6501","volume":"85","author":"GA Kaltsas","year":"2000","unstructured":"Kaltsas, G. A. et al. Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment. J. Clin. Endocrinol. Metab. 85, 1370\u20131376 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR80","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ejim.2017.11.011","volume":"51","author":"L Montefusco","year":"2018","unstructured":"Montefusco, L. et al. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis. Eur. J. Intern. Med. 51, 61\u201367 (2018).","journal-title":"Eur. J. Intern. Med."},{"key":"1200_CR81","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.tem.2007.06.003","volume":"18","author":"P Makras","year":"2007","unstructured":"Makras, P., Alexandraki, K. I., Chrousos, G. P., Grossman, A. B. & Kaltsas, G. A. Endocrine manifestations in Langerhans cell histiocytosis. Trends Endocrinol. Metab. 18, 252\u2013257 (2007).","journal-title":"Trends Endocrinol. Metab."},{"key":"1200_CR82","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/bloodadvances.2016001784","volume":"1","author":"JI Estrada-Veras","year":"2017","unstructured":"Estrada-Veras, J. I. et al. The clinical spectrum of Erdheim\u2013Chester disease: an observational cohort study. Blood Adv. 1, 357\u2013366 (2017).","journal-title":"Blood Adv."},{"key":"1200_CR83","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.02.004","volume":"95","author":"M Cives","year":"2015","unstructured":"Cives, M. et al. Erdheim\u2013Chester disease: a systematic review. Crit. Rev. Oncol. Hematol. 95, 1\u201311 (2015).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"1200_CR84","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1210\/jc.2010-2970","volume":"96","author":"P Leporati","year":"2011","unstructured":"Leporati, P., Landek-Salgado, M. A., Lupi, I., Chiovato, L. & Caturegli, P. IgG4-related hypophysitis: a new addition to the hypophysitis spectrum. J. Clin. Endocrinol. Metab. 96, 1971\u20131980 (2011). This article provides insights into IgG4-related hypophysitis, diagnosis and management.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR85","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1530\/EJE-13-0642","volume":"170","author":"H Bando","year":"2014","unstructured":"Bando, H. et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and\/or central diabetes insipidus and review of the literature. Eur. J. Endocrinol. 170, 161\u2013172 (2014).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2020.104016","volume":"49","author":"M Lojou","year":"2020","unstructured":"Lojou, M., Bonneville, J. F., Ebbo, M., Schleinitz, N. & Castinetti, F. IgG4 hypophysitis: diagnosis and management. Presse Med. 49, 104016 (2020).","journal-title":"Presse Med."},{"key":"1200_CR87","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/art.41120","volume":"72","author":"ZS Wallace","year":"2020","unstructured":"Wallace, Z. S. et al. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 72, 7\u201319 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1200_CR88","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace, Z. S. et al. IgG4-related disease: baseline clinical and laboratory features in 125 patients with biopsy-proven disease. Arthritis Rheumatol. 67, 2466\u20132475 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1200_CR89","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1002\/art.39686","volume":"68","author":"H Sekiguchi","year":"2016","unstructured":"Sekiguchi, H. et al. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 68, 2290\u20132299 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"1200_CR90","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1007\/s11102-024-01402-2","volume":"27","author":"M Verrienti","year":"2024","unstructured":"Verrienti, M., Picciola, V. M., Ambrosio, M. R. & Zatelli, M. C. Pituitary and COVID-19 vaccination: a systematic review. Pituitary 27, 970\u2013985 (2024).","journal-title":"Pituitary"},{"key":"1200_CR91","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1007\/s11102-024-01462-4","volume":"27","author":"S Menotti","year":"2024","unstructured":"Menotti, S., di Filippo, L., Terenzi, U., Chiloiro, S. & De Marinis, L. Hypophysitis in COVID-19: a systematic review. Pituitary 27, 874\u2013888 (2024).","journal-title":"Pituitary"},{"key":"1200_CR92","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1136\/ard.2010.143743","volume":"70","author":"R Seror","year":"2011","unstructured":"Seror, R. et al. EULAR Sj\u00f6gren\u2019s syndrome patient reported index (ESSPRI): development of a consensus patient index for primary Sj\u00f6gren\u2019s syndrome. Ann. Rheum. Dis. 70, 968\u2013972 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"1200_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-024-03845-3","volume":"24","author":"J Yum","year":"2024","unstructured":"Yum, J., Lee, S.-W., Rhee, Y. & Heo, K. Hypophysitis and central nervous system involvement in association with Sj\u00f6gren\u2019s syndrome along with hypoparathyroidism: a case report. BMC Neurol. 24, 339 (2024).","journal-title":"BMC Neurol."},{"issue":"Suppl 2","key":"1200_CR94","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1186\/s13023-020-01621-3","volume":"15","author":"B Terrier","year":"2020","unstructured":"Terrier, B. et al. French recommendations for the management of systemic necrotizing vasculitides (polyarteritis nodosa and ANCA-associated vasculitides). Orphanet J. Rare Dis. 15\u00a0(Suppl 2), 351 (2020).","journal-title":"Orphanet J. Rare Dis."},{"key":"1200_CR95","doi-asserted-by":"publisher","DOI":"10.1177\/2040622320930636","volume":"11","author":"C Li","year":"2020","unstructured":"Li, C., Zou, Y., Lu, X., Wang, G. & Shu, X. Pituitary dysfunction in patients with ANCA associated vasculitis: prevalence, presentation, and outcomes. Ther. Adv. Chronic Dis. 11, 2040622320930636 (2020).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"1200_CR96","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jns.2018.10.011","volume":"395","author":"H Mohammed","year":"2018","unstructured":"Mohammed, H. et al. Hypothalamic and pituitary dysfunction is common in tubercular meningitis: a prospective study from a tertiary care center in Northern India. J. Neurol. Sci. 395, 153\u2013158 (2018).","journal-title":"J. Neurol. Sci."},{"key":"1200_CR97","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/S0140-6736(19)30308-3","volume":"393","author":"J Furin","year":"2019","unstructured":"Furin, J., Cox, H. & Pai, M. Tuberculosis. Lancet 393, 1642\u20131656 (2019).","journal-title":"Lancet"},{"key":"1200_CR98","volume":"2017","author":"R Alves","year":"2017","unstructured":"Alves, R. & Fran\u00e7a, M. Subacute hypophysitis with panhypopituitarism as first presentation of HIV and syphilis coinfection. Case Rep. Infect. Dis. 2017, 1489210 (2017).","journal-title":"Case Rep. Infect. Dis."},{"key":"1200_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-13-481","volume":"13","author":"CD Spinner","year":"2013","unstructured":"Spinner, C. D. et al. Acute hypophysitis and hypopituitarism in early syphilitic meningitis in a HIV-infected patient: a case report. BMC Infect. Dis. 13, 481 (2013).","journal-title":"BMC Infect. Dis."},{"key":"1200_CR100","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17030436","volume":"17","author":"V Di Stasi","year":"2025","unstructured":"Di Stasi, V. et al. Immunotherapy-related hypophysitis: a narrative review. Cancers 17, 436 (2025).","journal-title":"Cancers"},{"key":"1200_CR101","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41574-024-01077-6","volume":"21","author":"S Iwama","year":"2025","unstructured":"Iwama, S., Kobayashi, T. & Arima, H. Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors. Nat. Rev. Endocrinol. 21, 289\u2013300 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1200_CR102","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1530\/EJE-19-0169","volume":"181","author":"F Albarel","year":"2019","unstructured":"Albarel, F., Castinetti, F. & Brue, T. Management of endocrine disease: immune check point inhibitors-induced hypophysitis. Eur. J. Endocrinol. 181, R107\u2013R118 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR103","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqae084","volume":"165","author":"N Chamorro-Pareja","year":"2024","unstructured":"Chamorro-Pareja, N., Faje, A. T. & Miller, K. K. Pituitary complications of checkpoint inhibitor use. Endocrinology 165, bqae084 (2024).","journal-title":"Endocrinology"},{"key":"1200_CR104","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1530\/EJE-19-0238","volume":"181","author":"A Faje","year":"2019","unstructured":"Faje, A. et al. Hypophysitis secondary to nivolumab and pembrolizumab is a clinical entity distinct from ipilimumab-associated hypophysitis. Eur. J. Endocrinol. 181, 211\u2013219 (2019).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR105","doi-asserted-by":"publisher","first-page":"230ra45","DOI":"10.1126\/scitranslmed.3008002","volume":"6","author":"S Iwama","year":"2014","unstructured":"Iwama, S. et al. Pituitary expression of CTLA-4 mediates hypophysitis secondary to administration of CTLA-4 blocking antibody. Sci. Transl. Med. 6, 230ra45 (2014).","journal-title":"Sci. Transl. Med."},{"key":"1200_CR106","doi-asserted-by":"publisher","first-page":"3706","DOI":"10.1002\/cncr.31629","volume":"124","author":"AT Faje","year":"2018","unstructured":"Faje, A. T. et al. High-dose glucocorticoids for the treatment of ipilimumab-induced hypophysitis is associated with reduced survival in patients with melanoma. Cancer 124, 3706\u20133714 (2018).","journal-title":"Cancer"},{"key":"1200_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9103280","volume":"9","author":"M Levy","year":"2020","unstructured":"Levy, M. et al. Anti-PD1 and anti-PDL1-induced hypophysitis: a cohort study of 17 patients with longitudinal follow-up. J. Clin. Med. 9, 3280 (2020).","journal-title":"J. Clin. Med."},{"key":"1200_CR108","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1097\/MED.0000000000000652","volume":"28","author":"A Kotwal","year":"2021","unstructured":"Kotwal, A. Hypophysitis from immune checkpoint inhibitors: challenges in diagnosis and management. Curr. Opin. Endocrinol. Diabetes Obes. 28, 424\u2013427 (2021).","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"1200_CR109","doi-asserted-by":"publisher","first-page":"4078","DOI":"10.1210\/jc.2014-2306","volume":"99","author":"AT Faje","year":"2014","unstructured":"Faje, A. T. et al. Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma. J. Clin. Endocrinol. Metab. 99, 4078\u20134085 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR110","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1530\/EJE-14-0845","volume":"172","author":"F Albarel","year":"2015","unstructured":"Albarel, F. et al. Long-term follow-up of ipilimumab-induced hypophysitis, a common adverse event of the anti-CTLA-4 antibody in melanoma. Eur. J. Endocrinol. 172, 195\u2013204 (2015).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR111","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1172\/JCI44073","volume":"121","author":"M Yamamoto","year":"2011","unstructured":"Yamamoto, M. et al. Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J. Clin. Invest. 121, 113\u2013119 (2011).","journal-title":"J. Clin. Invest."},{"key":"1200_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63183-x","volume":"16","author":"K Kanie","year":"2025","unstructured":"Kanie, K. et al. Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. Nat. Commun. 16, 7900 (2025).","journal-title":"Nat. Commun."},{"key":"1200_CR113","doi-asserted-by":"publisher","first-page":"E1744","DOI":"10.1210\/jc.2014-1769","volume":"99","author":"H Bando","year":"2014","unstructured":"Bando, H. et al. Involvement of PIT-1-reactive cytotoxic T lymphocytes in anti-PIT-1 antibody syndrome. J. Clin. Endocrinol. Metab. 99, E1744\u2013E1749 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR114","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41574-025-01099-8","volume":"21","author":"S Urai","year":"2025","unstructured":"Urai, S., Iguchi, G. & Takahashi, Y. Anti-PIT1 hypophysitis after immune checkpoint inhibitor treatment. Nat. Rev. Endocrinol. 21, 265\u2013266 (2025).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1200_CR115","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1002\/art.39011","volume":"67","author":"C Pagnoux","year":"2015","unstructured":"Pagnoux, C. et al. Treatment of systemic necrotizing vasculitides in patients aged sixty-five years or older: results of a multicenter, open-label, randomized controlled trial of corticosteroid and cyclophosphamide-based induction therapy. Arthritis Rheumatol. 67, 1117\u20131127 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1200_CR116","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1056\/NEJMoa1803537","volume":"382","author":"M Walsh","year":"2020","unstructured":"Walsh, M. et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N. Engl. J. Med. 382, 622\u2013631 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1200_CR117","doi-asserted-by":"publisher","first-page":"e1S","DOI":"10.1378\/chest.12-1044","volume":"142","author":"RP Baughman","year":"2012","unstructured":"Baughman, R. P. et al. Monitoring of nonsteroidal immunosuppressive drugs in patients with lung disease and lung transplant recipients. Chest 142, e1S\u2013e111S (2012).","journal-title":"Chest"},{"key":"1200_CR118","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/s11102-016-0769-3","volume":"20","author":"A Kyriacou","year":"2017","unstructured":"Kyriacou, A., Gnanalingham, K. & Kearney, T. Lymphocytic hypophysitis: modern day management with limited role for surgery. Pituitary 20, 241\u2013250 (2017).","journal-title":"Pituitary"},{"key":"1200_CR119","doi-asserted-by":"publisher","first-page":"3460","DOI":"10.1210\/jc.2015-2146","volume":"100","author":"J Honegger","year":"2015","unstructured":"Honegger, J. et al. Treatment of primary hypophysitis in Germany. J. Clin. Endocrinol. Metab. 100, 3460\u20133469 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR120","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11102-023-01367-8","volume":"27","author":"M Khaleghi","year":"2024","unstructured":"Khaleghi, M. et al. Successful treatment of medically and surgically refractory lymphocytic hypophysitis with fractionated stereotactic radiotherapy: a single-center experience and systematic literature review. Pituitary 27, 213\u2013229 (2024).","journal-title":"Pituitary"},{"key":"1200_CR121","volume":"12","author":"B Krishnappa","year":"2022","unstructured":"Krishnappa, B. et al. Glucocorticoid therapy as first-line treatment in primary hypophysitis: a systematic review and individual patient data meta-analysis. Endocr. Connect. 12, e220311 (2022).","journal-title":"Endocr. Connect."},{"key":"1200_CR122","doi-asserted-by":"publisher","first-page":"3877","DOI":"10.1210\/jc.2018-01021","volume":"103","author":"S Chiloiro","year":"2018","unstructured":"Chiloiro, S. et al. Hypophysitis outcome and factors predicting responsiveness to glucocorticoid therapy: a prospective and double-arm study. J. Clin. Endocrinol. Metab. 103, 3877\u20133889 (2018). This is the only clinical trial in hypophysitis to compare patients treated with glucocorticoids with untreated patients (12 and eight patients, respectively). Endocrine and radiological outcomes as well as adverse effects of treatment were evaluated.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1200_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-9-30","volume":"9","author":"D Liu","year":"2013","unstructured":"Liu, D. et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin. Immunol. 9, 30 (2013).","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"1200_CR124","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","volume":"190","author":"F Beuschlein","year":"2024","unstructured":"Beuschlein, F. et al. European Society of Endocrinology and Endocrine Society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur. J. Endocrinol. 190, G25\u2013G51 (2024).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR125","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1517\/14740338.2016.1140743","volume":"15","author":"M Oray","year":"2016","unstructured":"Oray, M., Abu Samra, K., Ebrahimiadib, N., Meese, H. & Foster, C. S. Long-term side effects of glucocorticoids. Expert. Opin. Drug. Saf. 15, 457\u2013465 (2016).","journal-title":"Expert. Opin. Drug. Saf."},{"key":"1200_CR126","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1507\/endocrj.K10E-334","volume":"58","author":"G-Q Yang","year":"2011","unstructured":"Yang, G.-Q. et al. Recurrent autoimmune hypophysitis successfully treated with glucocorticoids plus azathioprine: a report of three cases. Endocr. J. 58, 675\u2013683 (2011).","journal-title":"Endocr. J."},{"key":"1200_CR127","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/ejendo\/lvad115","volume":"189","author":"JD Vakharia","year":"2023","unstructured":"Vakharia, J. D. et al. A novel approach to hypophysitis: outcomes using non-glucocorticoid immunosuppressive therapy. Eur. J. Endocrinol. 189, 309\u2013317 (2023).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR128","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ando.2018.07.005","volume":"79","author":"F Castinetti","year":"2018","unstructured":"Castinetti, F. et al. Endocrine side-effects of new anticancer therapies: overall monitoring and conclusions. Ann. Endocrinol. 79, 591\u2013595 (2018).","journal-title":"Ann. Endocrinol."},{"key":"1200_CR129","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1182\/hematology.2023000439","volume":"2023","author":"O Abla","year":"2023","unstructured":"Abla, O. Langerhans cell histiocytosis: promises and caveats of targeted therapies in high-risk and CNS disease. Hematology 2023, 386\u2013395 (2023).","journal-title":"Hematology"},{"key":"1200_CR130","first-page":"1137","volume":"109","author":"E Cournoyer","year":"2024","unstructured":"Cournoyer, E. et al. Dabrafenib and trametinib in Langerhans cell histiocytosis and other histiocytic disorders. Haematologica 109, 1137\u20131148 (2024).","journal-title":"Haematologica"},{"key":"1200_CR131","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/onco.13541","volume":"25","author":"AZ Hazim","year":"2020","unstructured":"Hazim, A. Z. et al. Efficacy of BRAF-inhibitor therapy in BRAFV600E-mutated adult langerhans cell histiocytosis. Oncologist 25, 1001\u20131004 (2020).","journal-title":"Oncologist"},{"key":"1200_CR132","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1182\/blood.2019003507","volume":"135","author":"G Goyal","year":"2020","unstructured":"Goyal, G. et al. Erdheim\u2013Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 135, 1929\u20131945 (2020).","journal-title":"Blood"},{"key":"1200_CR133","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1530\/EJE-20-0652","volume":"183","author":"F Albarel","year":"2020","unstructured":"Albarel, F. et al. Evaluation of an individualized education program in pituitary diseases: a pilot study. Eur. J. Endocrinol. 183, 551\u2013559 (2020).","journal-title":"Eur. J. Endocrinol."},{"key":"1200_CR134","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1056\/NEJM197910253011705","volume":"301","author":"VJ Nessan","year":"1979","unstructured":"Nessan, V. J., Jacoway, J. R., Lauttman, R. J., Swintak, E. F. & Buhler, J. E. Biopsy of minor salivary glands in the diagnosis of sarcoidosis. N. Engl. J. Med. 301, 922\u2013924 (1979).","journal-title":"N. Engl. J. Med."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01200-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01200-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:02:36Z","timestamp":1776297756000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-025-01200-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":134,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1200"],"URL":"https:\/\/doi.org\/10.1038\/s41574-025-01200-1","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"10 October 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}